---
figid: PMC5332883__jcav08p0332g001
figlink: /pmc/articles/PMC5332883/figure/F1/
number: Figure 1
caption: Potential for PD-L1 modulation in HNSCC. Members of the EGFR, STAT, PI3K,
  p53, and HIF-1α signaling pathways, all of which may be de-regulated in HNSCC, are
  shown. EGFR is aberrantly activated in HNSCC and may promote PD-L1 transcription
  via JAK/STAT or MEK/ERK signaling. IFN-γ induces PD-L1 transcription in HSCC via
  JAK/STAT signaling, and may also activate the PI3K signaling pathway, which regulates
  PD-L1 transcription in other cancers. HIF-1α binds directly to the PD-L1 promoter
  and correlates with high PD-L1 expression. p53 loss of function is common in HNSCC,
  and wild type p53 blocks PD-L1 translation via transcription of miR-34. Also shown
  are targeted small molecule inhibitors and biologics currently being evaluated in
  active clinical trials open to HNSCC patients. Red text indicates inhibitors for
  which efficacy in combination with PD-1/PD-L1 blockade is being evaluated. Table
  (lower right) is based upon data generated by the TCGA Research Network (http://cancergenome.nih.gov).
  The middle column denotes the percentage of 504 cases with alternations (mutations
  or copy number variations) in the indicated gene. Within this dataset, 35 of 106
  cases in which p16 was assessed were designated HPV positive. The rightmost column
  denotes the percentage of HPV positive cases with alterations in the indicated gene
  .
pmcid: PMC5332883
papertitle: Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted
  Therapy in HNSCC.
reftext: JE Mann, et al. J Cancer. 2017;8(3):332-344.
pmc_ranked_result_index: '113962'
pathway_score: 0.9754686
filename: jcav08p0332g001.jpg
figtitle: For PD-L1 modulation in HNSCC
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5332883__jcav08p0332g001.html
  '@type': Dataset
  description: Potential for PD-L1 modulation in HNSCC. Members of the EGFR, STAT,
    PI3K, p53, and HIF-1α signaling pathways, all of which may be de-regulated in
    HNSCC, are shown. EGFR is aberrantly activated in HNSCC and may promote PD-L1
    transcription via JAK/STAT or MEK/ERK signaling. IFN-γ induces PD-L1 transcription
    in HSCC via JAK/STAT signaling, and may also activate the PI3K signaling pathway,
    which regulates PD-L1 transcription in other cancers. HIF-1α binds directly to
    the PD-L1 promoter and correlates with high PD-L1 expression. p53 loss of function
    is common in HNSCC, and wild type p53 blocks PD-L1 translation via transcription
    of miR-34. Also shown are targeted small molecule inhibitors and biologics currently
    being evaluated in active clinical trials open to HNSCC patients. Red text indicates
    inhibitors for which efficacy in combination with PD-1/PD-L1 blockade is being
    evaluated. Table (lower right) is based upon data generated by the TCGA Research
    Network (http://cancergenome.nih.gov). The middle column denotes the percentage
    of 504 cases with alternations (mutations or copy number variations) in the indicated
    gene. Within this dataset, 35 of 106 cases in which p16 was assessed were designated
    HPV positive. The rightmost column denotes the percentage of HPV positive cases
    with alterations in the indicated gene .
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - PDK1
  - MAPK3
  - NFKB1
  - NFKB2
  - EGFR
  - TP53
  - PRKCI
  - REL
  - AKT1
  - PRKCA
  - PRKCQ
  - RELA
  - PRKCE
  - PRKCH
  - PRKCB
  - PRKCD
  - JAK3
  - PDK2
  - JAK1
  - JAK2
  - AKT2
  - RELB
  - MAP2K1
  - CD274
  - PRKCG
  - HIF1A
  - PDK3
  - AKT3
  - TYK2
  - MAP2K2
  - STAT3
  - PDK4
  - PRKD3
  - STAT1
  - PRKCZ
  - PTEN
  - SF1126
  - Ruxolitinib
  - Cancer
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: (p53)
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PDK1/2
  symbol: PDK2
  source: hgnc_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: PDK1/2
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PRKCA
  symbol: PRKCA
  source: hgnc_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: MAPK1
  symbol: MAPK1
  source: hgnc_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: JAK1/2
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK1/2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
chemicals:
- word: SF1126
  source: MESH
  identifier: C526549
- word: Ruxolitinib
  source: MESH
  identifier: C540383
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
